September 24, 2017 11:26 PM ET


Company Overview of Noven Pharmaceuticals, Inc.

Company Overview

Noven Pharmaceuticals, Inc. engages in the research, development, manufacture, marketing, and sale of prescription pharmaceutical products in the United States. The company’s products focus on women’s health, as well as central nervous system disorders, including attention deficit hyperactivity disorder (ADHD). Its products include Brisdelle, a non-hormonal therapy for vasomotor symptoms associated with menopause; Minivelle, an estrogen therapy patch for the treatment of vasomotor symptoms due to menopause and prevention of post-menopausal osteoporosis; CombiPatch, an estradiol/norethindrone acetate transdermal system to treat symptoms of hot flashes, and vaginal dryness associated with meno...

11960 SW 144th Street

Miami, FL 33186

United States

Founded in 1987

610 Employees





Key Executives for Noven Pharmaceuticals, Inc.

Chief Executive Officer and Director
Chief Financial Officer, Vice President and Treasurer
Vice President of Operations
Chief Medical Officer and Executive Vice President of Product Development
Age: 62
Chief Scientific Officer and Vice President
Compensation as of Fiscal Year 2017.

Noven Pharmaceuticals, Inc. Key Developments

Noven Pharmaceuticals, Inc. Appoints Mark Jackson as New Vice President – Quality

Noven Pharmaceuticals, Inc. announced the appointment of Mark Jackson, as the company’s new vice president – quality. In this role, Jackson will be responsible for overseeing all of the company’s activities related to Quality Assurance, Quality Control and Compliance. Jackson will report to Jeff Mihm, Noven’s chief executive officer. Jackson has over 30 years’ experience in the pharmaceutical and medical device industries. He joins Noven from HeartWare, Inc., where he served as the vice president of quality and design assurance.

Noven Pharmaceuticals, Inc. Appoints Ralph Lipp as Vice President and Chief Scientific Officer

Noven Pharmaceuticals, Inc. announced the appointment of Ralph Lipp as the company’s new Vice President and Chief Scientific Officer. In this role, Lipp will lead all Research and Development efforts for the company’s transdermal drug delivery programs and related product development activities. Dr. Lipp will report to Jeff Mihm, Chief Executive Officer. Lipp has more than 25 years of experience in transdermals and drug delivery including 14 years at Schering A.G., where he rose to the position of Head of Pharmaceutical Development.

Noven Pharmaceuticals, Inc. Presents at BioNetwork West Partnering Summit 2016, Oct-06-2016 01:40 PM

Noven Pharmaceuticals, Inc. Presents at BioNetwork West Partnering Summit 2016, Oct-06-2016 01:40 PM. Venue: The Ritz-Carlton, Laguna Niguel, California, United States. Speakers: Patrick Gallagher, Vice President of Business Development.

Similar Private Companies By Industry

Company Name Region
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
4P Therapeutics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Noven Pharmaceuticals, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at